18/07/2022

EuropaBio Statement on the proposal for a Regulation on substances of human origin (SoHO)

16/05/2022

EuropaBio Statement on the Evaluation of the Cross-Border Healthcare Directive

31/05/2021

EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021

12/02/2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

29/01/2021

Building a European Health Union

20/01/2021

Revision of the EU legislation on medicines for children and rare diseases

30/11/2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

20/10/2020

EuropaBio on Use of Real-World Data (RWD) and Real-World Evidence (RWE) for regulatory decision-making

19/10/2020

Application of the ATMP Hospital Exemption in the EU

30/09/2020

EuropaBio Patient engagement with the European Medicines Agency

13/08/2020

Statement in response to the publication of the European Commission’s evaluation of the Orphan and Paediatric Regulations

03/08/2020

Joint Statement on the Health Innovation Partnership Proposal